Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CAPR NASDAQ:INNV NASDAQ:PDSB NASDAQ:SNNA OTCMKTS:WCUI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAPRCapricor Therapeutics$6.22+3.0%$7.23$4.59▼$23.40$276.13M0.731.17 million shs822,707 shsINNVInnovAge$5.18+4.0%$3.84$2.60▼$6.69$675.48M0.5230,305 shs53,906 shsPDSBPDS Biotechnology$1.20+3.4%$1.19$0.85▼$4.29$54.55M1.15544,056 shs358,260 shsSNNASienna Biopharmaceuticals$0.14$0.14$0.06▼$3.80$4.20M2.671.87 million shs13.32 million shsWCUIWellness Center Usa$0.00$0.00▼$0.04$10K4.71100,000 shs100,000 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAPRCapricor Therapeutics+2.98%-4.01%-21.86%-47.91%+41.04%INNVInnovAge+4.02%+21.31%+51.02%+36.68%-12.35%PDSBPDS Biotechnology+3.45%+1.69%+0.84%-25.47%-60.78%SNNASienna Biopharmaceuticals0.00%0.00%0.00%0.00%0.00%WCUIWellness Center Usa0.00%0.00%0.00%-81.82%-50.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAPRCapricor Therapeutics$6.22+3.0%$7.23$4.59▼$23.40$276.13M0.731.17 million shs822,707 shsINNVInnovAge$5.18+4.0%$3.84$2.60▼$6.69$675.48M0.5230,305 shs53,906 shsPDSBPDS Biotechnology$1.20+3.4%$1.19$0.85▼$4.29$54.55M1.15544,056 shs358,260 shsSNNASienna Biopharmaceuticals$0.14$0.14$0.06▼$3.80$4.20M2.671.87 million shs13.32 million shsWCUIWellness Center Usa$0.00$0.00▼$0.04$10K4.71100,000 shs100,000 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAPRCapricor Therapeutics+2.98%-4.01%-21.86%-47.91%+41.04%INNVInnovAge+4.02%+21.31%+51.02%+36.68%-12.35%PDSBPDS Biotechnology+3.45%+1.69%+0.84%-25.47%-60.78%SNNASienna Biopharmaceuticals0.00%0.00%0.00%0.00%0.00%WCUIWellness Center Usa0.00%0.00%0.00%-81.82%-50.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCAPRCapricor Therapeutics 3.11Buy$22.56262.63% UpsideINNVInnovAge 1.50Reduce$5.00-3.47% DownsidePDSBPDS Biotechnology 3.00Buy$10.00733.33% UpsideSNNASienna Biopharmaceuticals 0.00N/AN/AN/AWCUIWellness Center Usa 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PDSB, INNV, SNNA, CAPR, and WCUI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/11/2025CAPRCapricor TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$24.007/14/2025CAPRCapricor TherapeuticsAlliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy7/14/2025CAPRCapricor TherapeuticsRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$31.00 ➝ $12.007/11/2025CAPRCapricor TherapeuticsPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$20.007/11/2025CAPRCapricor TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$77.00 ➝ $24.007/1/2025PDSBPDS BiotechnologyHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$13.006/30/2025CAPRCapricor TherapeuticsAlliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$20.006/26/2025CAPRCapricor TherapeuticsB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$21.006/25/2025CAPRCapricor TherapeuticsB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy6/25/2025CAPRCapricor TherapeuticsJones TradingSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$40.00 ➝ $29.006/24/2025CAPRCapricor TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$77.00(Data available from 9/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCAPRCapricor Therapeutics$22.27M12.77N/AN/A$3.20 per share1.94INNVInnovAge$853.70M0.82N/AN/A$1.76 per share2.94PDSBPDS BiotechnologyN/AN/AN/AN/A$0.51 per shareN/ASNNASienna BiopharmaceuticalsN/AN/AN/AN/A$1.27 per shareN/AWCUIWellness Center Usa$660K0.00N/AN/AN/ANaNCompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCAPRCapricor Therapeutics-$40.47M-$1.64N/AN/AN/A-181.71%-62.71%-50.82%11/12/2025 (Estimated)INNVInnovAge-$30.31M-$0.23N/A86.33N/A-3.55%-12.02%-5.73%11/4/2025 (Estimated)PDSBPDS Biotechnology-$37.61M-$0.92N/AN/AN/AN/A-184.56%-79.00%11/13/2025 (Estimated)SNNASienna Biopharmaceuticals-$73.47M-$3.59N/AN/AN/AN/A-177.36%-52.22%N/AWCUIWellness Center Usa-$750KN/A0.00N/AN/AN/AN/AN/AN/ALatest PDSB, INNV, SNNA, CAPR, and WCUI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/9/2025Q4 2025INNVInnovAge-$0.02-$0.01+$0.01-$0.01$219.80 million$221.42 million8/13/2025Q2 2025PDSBPDS Biotechnology-$0.24-$0.21+$0.03-$0.21N/AN/A8/11/2025Q2 2025CAPRCapricor Therapeutics-$0.48-$0.57-$0.09-$0.57$2.60 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCAPRCapricor TherapeuticsN/AN/AN/AN/AN/AINNVInnovAgeN/AN/AN/AN/AN/APDSBPDS BiotechnologyN/AN/AN/AN/AN/ASNNASienna BiopharmaceuticalsN/AN/AN/AN/AN/AWCUIWellness Center UsaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCAPRCapricor TherapeuticsN/A4.374.37INNVInnovAge0.271.071.07PDSBPDS Biotechnology0.812.922.92SNNASienna BiopharmaceuticalsN/A15.2715.27WCUIWellness Center UsaN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCAPRCapricor Therapeutics21.68%INNVInnovAge12.26%PDSBPDS Biotechnology26.84%SNNASienna Biopharmaceuticals17.36%WCUIWellness Center Usa0.01%Insider OwnershipCompanyInsider OwnershipCAPRCapricor Therapeutics10.50%INNVInnovAge1.40%PDSBPDS Biotechnology9.20%SNNASienna Biopharmaceuticals27.20%WCUIWellness Center Usa15.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCAPRCapricor Therapeutics10145.72 million40.92 millionOptionableINNVInnovAge2,440135.64 million133.74 millionOptionablePDSBPDS Biotechnology2047.03 million42.70 millionOptionableSNNASienna Biopharmaceuticals3930.91 millionN/ANot OptionableWCUIWellness Center Usa8143.19 million120.71 millionNot OptionablePDSB, INNV, SNNA, CAPR, and WCUI HeadlinesRecent News About These CompaniesAll In Solutions Wellness Center Sets Benchmark with Personalized Rehab Success RateSeptember 16 at 5:40 PM | tennessean.comTStudent Wellness Center holds first of three trainings on opioid safety and responseSeptember 12, 2025 | newsrecord.orgNLassen County Office of Education launches New Wellness Center websiteSeptember 11, 2025 | lassennews.comLNorthwest ISD to open free Student Wellness Center at flagship campusSeptember 11, 2025 | crosstimbersgazette.comCWellness Center Usa (OTCMKTS:WCUI) and Beauty Health (NASDAQ:SKIN) Financial ContrastSeptember 7, 2025 | americanbankingnews.comRep. Hunschofsky, Sen. Polsky Present $350K in State Funding to Eagles’ Haven Wellness CenterSeptember 3, 2025 | parklandtalk.comPRep. Hunschofsky, Sen. Polsky Present $350K in State Funding to Eagles’ Haven Wellness CenterSeptember 3, 2025 | parklandtalk.comPWellness Expert and Master Injector Natalya Celi Joins Staff at Parkland Medspa & Wellness CenterAugust 28, 2025 | finance.yahoo.comDemolition begins on Norfolk Fitness and Wellness Center Dome to make way for new facilityAugust 7, 2025 | msn.comdidgwalic Wellness Center to host March Against AddictionAugust 1, 2025 | goskagit.comGTribe to celebrate grand opening of Mary L. (Holland) Carson Wellness Center in StilwellAugust 1, 2025 | tahlequahdailypress.comTMall at Wellington Green's makeover continues as local wellness center relocates thereJuly 19, 2025 | ftw.usatoday.comJasper considering funding options for Regional Wellness CenterJuly 19, 2025 | duboiscountyfreepress.comDHealing begins where taboos end at SIU Pelvic Wellness CenterJuly 16, 2025 | nprillinois.orgNRagin Wellness Center offering trauma therapy to young people in SumterJuly 16, 2025 | abccolumbia.comA5 walkouts of mentally ill patients prompt policy reform at Guam Behavioral Health and Wellness CenterJuly 13, 2025 | guampdn.comGForty Fort Parks and Recreation Committee donates to Cancer Wellness Center of NEPAJuly 13, 2025 | timesleader.comTLamar Mental Wellness Center in Augusta aids mental health needsJuly 11, 2025 | msn.comFlagler Schools cut ribbon on new Wellness CenterJuly 9, 2025 | observerlocalnews.comOWest Monroe Honors Local Businesses with “Yard of the Month” Award for Outstanding Beautification to The Wellness CenterJuly 5, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePDSB, INNV, SNNA, CAPR, and WCUI Company DescriptionsCapricor Therapeutics NASDAQ:CAPR$6.22 +0.18 (+2.98%) Closing price 09/16/2025 04:00 PM EasternExtended Trading$6.24 +0.02 (+0.24%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Capricor Therapeutics, Inc. (NASDAQ:CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. Capricor's lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy. Capricor has also established itself as one of the leading companies investigating the field of extracellular vesicles and is exploring the potential of CAP-2003, a cell-free, exosome-based candidate, to treat a variety of disorders. InnovAge NASDAQ:INNV$5.18 +0.20 (+4.02%) Closing price 09/16/2025 04:00 PM EasternExtended Trading$5.20 +0.02 (+0.29%) As of 09/16/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.PDS Biotechnology NASDAQ:PDSB$1.20 +0.04 (+3.45%) Closing price 09/16/2025 04:00 PM EasternExtended Trading$1.20 0.00 (0.00%) As of 09/16/2025 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, and human papillomavirus associated malignancies. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein (TARP) for treating prostate and breast cancers; and PDS0103 for ovarian, colorectal, lung, and breast cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment; and PDS0104, a novel investigational Tyrosinase-related Protein 2 targeted immunotherapy that stimulates a potent targeted T cell attack against melanoma. Further, the company provides PDS0202, a novel investigational influenza vaccine that generates broad and robust antibody and T cell responses that provide protection against continually evolving strains of seasonal flu and potentially emerging pandemic flu. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. The company was founded in 2005 and is based in Princeton, New Jersey.Sienna Biopharmaceuticals NASDAQ:SNNASienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.Wellness Center Usa OTCMKTS:WCUIWellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Resideo Technologies: Institutional Activity Signals 30% Upside Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Palantir’s Commercial Growth Story Is Just Getting Started How Bath & Body Works Is a Perfect Example of a Value Stock The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Uranium Energy Stock Has Momentum—and More Upside Ahead Why Opendoor Stock Is Soaring—and May Just Be Starting Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
